Vir Biotechnology, Inc.
VIR
30 insider filings · Latest: Aug 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Feb 26 9:56 PM | Brent SabatiniSVP, Chief Accounting Officer | Sale | 1,430 | $9.53 | $13.6K | 69,613(D) | View → |
| Feb 24, 2026 | Feb 26 9:55 PM | Jason O'ByrneEVP & Chief Financial Officer | Sale | 1,634 | $9.53 | $15.6K | 162,615(D) | View → |
| Feb 25, 2026 | Feb 26 9:55 PM | Mark EisnerEVP and Chief Medical Officer | Sale | 1,889 | $9.82 | $18.5K | 154,024(D) | View → |
| Feb 24, 2026 | Feb 26 9:55 PM | Mark EisnerEVP and Chief Medical Officer | Sale | 1,616 | $9.53 | $15.4K | 155,913(D) | View → |
| Feb 25, 2026 | Feb 26 9:54 PM | Verneuil Vanina deEVP, General Counsel, Corp Sec | Sale | 13,700 | $9.82 | $134.5K | 112,982(D) | View → |
| Feb 24, 2026 | Feb 26 9:54 PM | Verneuil Vanina deEVP, General Counsel, Corp Sec | Sale | 3,117 | $9.53 | $29.7K | 126,682(D) | View → |
| Feb 24, 2026 | Feb 26 9:54 PM | Backer Marianne DeDirector, Chief Executive Officer | Sale | 14,762 | $9.53 | $140.7K | 1,020,704(D) | View → |
| Feb 25, 2026 | Feb 26 2:00 AM | SVF Endurance (Cayman) Limited | Proposed Sale | 400,000 | $9.49 | $3.8M | — | View → |
| Feb 25, 2026 | Feb 25 3:48 PM | de Verneuil Vanina | Proposed Sale | 13,700 | $9.82 | $134.5K | — | View → |
| Feb 25, 2026 | Feb 25 2:48 PM | Eisner Mark | Proposed Sale | 1,889 | $9.82 | $18.5K | — | View → |
| Feb 23, 2026 | Feb 25 12:13 AM | Brent SabatiniSVP, Chief Accounting Officer | Sale | 1,829 | $7.45 | $13.6K | 71,043(D) | View → |
| Feb 23, 2026 | Feb 25 12:12 AM | Jason O'ByrneEVP & Chief Financial Officer | Sale | 2,089 | $7.45 | $15.6K | 164,249(D) | View → |
| Feb 23, 2026 | Feb 25 12:11 AM | Mark EisnerEVP and Chief Medical Officer | Sale | 2,089 | $7.45 | $15.6K | 157,529(D) | View → |
| Feb 23, 2026 | Feb 25 12:10 AM | Verneuil Vanina deEVP, General Counsel, Corp Sec | Sale | 4,445 | $7.45 | $33.1K | 129,799(D) | View → |
| Feb 23, 2026 | Feb 25 12:09 AM | Backer Marianne DeDirector, Chief Executive Officer | Sale | 19,039 | $7.45 | $141.9K | 1,035,466(D) | View → |
| Feb 24, 2026 | Feb 24 10:16 PM | Eisner Mark | Proposed Sale | 1,616 | $9.53 | $15.4K | — | View → |
| Feb 24, 2026 | Feb 24 10:07 PM | De Backer Marianne | Proposed Sale | 14,762 | $9.53 | $140.7K | — | View → |
| Feb 24, 2026 | Feb 24 9:57 PM | O'Byrne Jason | Proposed Sale | 1,634 | $9.53 | $15.6K | — | View → |
| Feb 24, 2026 | Feb 24 9:53 PM | Sabatini Brent | Proposed Sale | 1,430 | $9.53 | $13.6K | — | View → |
| Feb 24, 2026 | Feb 24 9:42 PM | de Verneuil Vanina | Proposed Sale | 3,117 | $9.53 | $29.7K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 10 10:21 PM | Timothy CoughlinDirector | Grant/Award | 32,000 | $8.51 | 16,000(D) | View → |
| May 27, 2026 | May 28 11:25 PM | Charles Elliott SigalDirector | Grant/Award | 16,000 | $9.10 | 16,000(D) | View → |
| May 27, 2026 | May 28 11:25 PM | Janet NapolitanoDirector | Grant/Award | 16,000 | $9.10 | 16,000(D) | View → |
| May 27, 2026 | May 28 11:25 PM | Robert J MoreDirector | Grant/Award | 16,000 | $9.10 | 16,000(D) | View → |
| May 27, 2026 | May 28 11:24 PM | Jeffrey S. HatfieldDirector | Grant/Award | 16,000 | $9.10 | 16,000(D) | View → |
| May 27, 2026 | May 28 11:24 PM | Ramy FaridDirector | Grant/Award | 16,000 | $9.10 | 16,000(D) | View → |
| May 27, 2026 | May 28 11:23 PM | BISCHOFBERGER NORBERT WDirector | Grant/Award | 16,000 | $9.10 | 16,000(D) | View → |
| Feb 24, 2026 | Feb 26 9:56 PM | Vicki L SatoDirector | Option Exercise | 42,377 | $1.49 | 0(D) | View → |
| Feb 22, 2026 | Feb 25 12:13 AM | Brent SabatiniSVP, Chief Accounting Officer | Grant/Award | 50,000 | $7.56 | 50,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:12 AM | Jason O'ByrneEVP & Chief Financial Officer | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:11 AM | Mark EisnerEVP and Chief Medical Officer | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:10 AM | Verneuil Vanina deEVP, General Counsel, Corp Sec | Grant/Award | 110,000 | $7.56 | 110,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:09 AM | Backer Marianne DeDirector, Chief Executive Officer | Grant/Award | 570,000 | $7.56 | 570,000(D) | View → |